You need to create a user account to read this article.
With a subscription you unlock more content on BioStock.
As you know, BioStock keeps its ear to the ground regarding where the biotech sector is headed. There are more and more signals that money is starting to find its way back into our badly damaged industry. The question...
Previous chronicles
The thermometer reads 78 degrees of winter chill – but the forecast promises spring sun
From green shoots to record highs – the turnaround is here
Flerie continues to cherry-pick the best opportunities
AI braces for a crash – biotech waits for retail to return
The generalists about to jump on the bandwagon
Pfizer’s whining confirm it – Metsera is the perfect fit for Novo
All power to Sørensen – more turbulence ahead
Biotech shows increasing signs of life – is there more upside?
Big pharma ditches the UK – A stark warning
Is Nordic life science on sale?
You deserve the best!
Unlock our premium content: Become a subscriber!
Create Account